• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重短暂性 ADAMTS13 缺乏症与肺炎球菌相关性溶血尿毒综合征。

Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.

机构信息

Service de Pédiatrie, Hôpital Pellegrin-Enfants, Centre Hospitalier Universitaire, Bordeaux, France.

出版信息

Pediatr Nephrol. 2011 Apr;26(4):631-5. doi: 10.1007/s00467-010-1721-9. Epub 2010 Dec 15.

DOI:10.1007/s00467-010-1721-9
PMID:21161282
Abstract

Thrombotic microangiopathies comprise different entities, including hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions. TTP is characterized by hemolytic anemia, thrombocytopenia, and multiorgan failure. TTP is the result of severe von Willebrand factor multimer cleaving protease (ADAMTS13) deficiency that is either inherited or the result of acquired autoantibodies. We report a critically ill 2-year-old girl with invasive pneumococcal disease associated HUS (p-HUS) whose condition was complicated by severe ADAMTS13 deficiency, without detectable inhibitor, in a context of multiple organ failure. The patient recovered with supportive treatment, and ADAMTS13 activity normalized without plasmatherapy. Severe ADAMTS13 deficiency appears to be a manifestation of transient endothelial cell injury in the context of severe sepsis, including invasive p-HUS. The choice of appropriate therapy should not be based on this finding.

摘要

血栓性微血管病包括不同的疾病实体,包括溶血性尿毒症综合征(HUS)、血栓性血小板减少性紫癜(TTP)和其他几种疾病。TTP 的特征是溶血性贫血、血小板减少和多器官衰竭。TTP 是由于严重的 von Willebrand 因子多聚体裂解蛋白酶(ADAMTS13)缺乏引起的,这种缺乏可能是遗传性的,也可能是获得性自身抗体的结果。我们报告了一例患有侵袭性肺炎球菌病相关 HUS(p-HUS)的危重症 2 岁女孩,其病情因严重的 ADAMTS13 缺乏而复杂化,且缺乏可检测的抑制剂,同时伴有多器官衰竭。该患者接受支持性治疗后康复,ADAMTS13 活性在未进行血浆治疗的情况下恢复正常。严重的 ADAMTS13 缺乏似乎是严重脓毒症包括侵袭性 p-HUS 时内皮细胞一过性损伤的表现。选择适当的治疗方法不应基于这一发现。

相似文献

1
Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome.严重短暂性 ADAMTS13 缺乏症与肺炎球菌相关性溶血尿毒综合征。
Pediatr Nephrol. 2011 Apr;26(4):631-5. doi: 10.1007/s00467-010-1721-9. Epub 2010 Dec 15.
2
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.血栓性血小板减少性紫癜和其他血栓性微血管病性溶血性贫血:诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):584-6. doi: 10.1016/j.autrev.2014.01.004. Epub 2014 Jan 11.
3
Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?恶性高血压与溶血尿毒综合征(HUS)/血栓性血小板减少性紫癜(TTP)中的血栓性微血管病:我们能将两者区分开吗?
Hypertens Res. 2005 Jan;28(1):89-95. doi: 10.1291/hypres.28.89.
4
Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).血栓性血小板减少性紫癜/溶血性尿毒症综合征(TTP/HUS)中的两种新型ADAMTS13基因突变。
Kidney Int. 2004 Sep;66(3):955-8. doi: 10.1111/j.1523-1755.2004.00841.x.
5
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.血栓性血小板减少性紫癜和溶血尿毒综合征的病因及发病机制:血管性血友病因子裂解蛋白酶的作用
Best Pract Res Clin Haematol. 2001 Jun;14(2):437-54. doi: 10.1053/beha.2001.0142.
6
[Pathophysiology of thrombotic microangiopathies: current understanding].[血栓性微血管病的病理生理学:当前认识]
Ann Med Interne (Paris). 2002 May;153(3):153-66.
7
The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.血栓性血小板减少性紫癜与非典型溶血尿毒综合征的复杂鉴别诊断:实验室武器及其对治疗选择和监测的影响。
Thromb Res. 2015 Nov;136(5):851-4. doi: 10.1016/j.thromres.2015.09.007. Epub 2015 Sep 12.
8
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.血管性血友病因子裂解蛋白酶(ADAMTS13)在复发性和家族性血栓性血小板减少性紫癜及溶血性尿毒症综合征中缺乏。
Blood. 2002 Aug 1;100(3):778-85. doi: 10.1182/blood-2001-12-0166.
9
Recent advances in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的最新进展
Hematology Am Soc Hematol Educ Program. 2004:407-23. doi: 10.1182/asheducation-2004.1.407.
10
Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.日本919例血栓性微血管病患者登记:奈良医科大学1998 - 2008年数据库
Intern Med. 2010;49(1):7-15. doi: 10.2169/internalmedicine.49.2706. Epub 2010 Jan 1.

引用本文的文献

1
Bacteremia with Acute Kidney Injury and Transient ADAMTS13 Deficiency.伴有急性肾损伤和短暂性ADAMTS13缺乏的菌血症
Case Rep Infect Dis. 2023 Apr 29;2023:3283606. doi: 10.1155/2023/3283606. eCollection 2023.
2
Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis.ADAMTS 13活性降低与儿童重症脓毒症的疾病严重程度及预后相关。
Medicine (Baltimore). 2016 Apr;95(16):e3374. doi: 10.1097/MD.0000000000003374.
3
The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation.

本文引用的文献

1
Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.利妥昔单抗治疗获得性 ADAMTS13 缺乏相关急性难治性血栓性血小板减少性紫癜成功:儿科报告及文献复习。
Pediatr Crit Care Med. 2011 Mar;12(2):e90-3. doi: 10.1097/PCC.0b013e3181e89f8f.
2
Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.肺炎链球菌相关性溶血尿毒综合征:分类及 19A 血清型的出现。
Pediatrics. 2010 Jan;125(1):e174-82. doi: 10.1542/peds.2007-2017. Epub 2009 Dec 21.
3
Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.
ADAMTS13(含Ⅰ型血小板反应蛋白基序的解聚素样金属蛋白酶13)缺乏在脓毒性休克患者中的预后价值涉及白细胞介素-6,且不依赖于弥散性血管内凝血。
Crit Care. 2013 Nov 18;17(6):R273. doi: 10.1186/cc13115.
4
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.ADAMTS13 可预测 2 型糖尿病患者的肾脏和心血管事件及治疗反应。
Diabetes. 2013 Oct;62(10):3599-609. doi: 10.2337/db13-0530. Epub 2013 Jun 3.
强化血浆置换可增加具有血小板反应蛋白基序的解聚素和金属蛋白酶13的活性,并逆转血小板减少症相关性多器官功能衰竭患儿的器官功能障碍。
Crit Care Med. 2008 Oct;36(10):2878-87. doi: 10.1097/ccm.0b013e318186aa49.
4
A severe case of atypical hemolytic uremic syndrome associated with pneumococcal infection and T activation treated successfully with plasma exchange.一例与肺炎球菌感染和T细胞激活相关的重症非典型溶血性尿毒症综合征经血浆置换成功治疗。
Transfusion. 2008 Nov;48(11):2448-52. doi: 10.1111/j.1537-2995.2008.01871.x. Epub 2008 Jul 30.
5
Complement and the atypical hemolytic uremic syndrome in children.补体与儿童非典型溶血尿毒综合征
Pediatr Nephrol. 2008 Nov;23(11):1957-72. doi: 10.1007/s00467-008-0872-4. Epub 2008 Jul 2.
6
The Ashwell receptor mitigates the lethal coagulopathy of sepsis.阿什韦尔受体可减轻脓毒症的致死性凝血病。
Nat Med. 2008 Jun;14(6):648-55. doi: 10.1038/nm1760. Epub 2008 May 18.
7
Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?一名17岁患者的血栓性微血管病:是血栓性血小板减少性紫癜、溶血尿毒症综合征,还是两者皆有?
Clin Nephrol. 2007 Dec;68(6):405-11. doi: 10.5414/cnp68405.
8
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.来自IgA肾病患者的分泌IgA1的细胞系产生异常糖基化的IgA1。
J Clin Invest. 2008 Feb;118(2):629-39. doi: 10.1172/JCI33189.
9
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure.ADAMTS-13(一种含血小板反应蛋白基序的解整合素样金属蛋白酶)水平降低与脓毒症诱导的器官衰竭预后不良相关。
Crit Care Med. 2007 Oct;35(10):2375-82. doi: 10.1097/01.ccm.0000284508.05247.b3.
10
The thrombotic microangiopathies.血栓性微血管病
Pediatr Nephrol. 2008 Oct;23(10):1761-7. doi: 10.1007/s00467-007-0616-x. Epub 2007 Sep 30.